CL2008003809A1 - Composicion en polvo nutricional que comprende carboidratos, lipidos con 0,25 a 2,5% de lecitina, 90 a 99,5% de proteina intacta y 0,5 a 10% de proteina de suero con un grado de hidrolisis de entre 23 y 90%; y composiciones nutricionales para bebes. - Google Patents

Composicion en polvo nutricional que comprende carboidratos, lipidos con 0,25 a 2,5% de lecitina, 90 a 99,5% de proteina intacta y 0,5 a 10% de proteina de suero con un grado de hidrolisis de entre 23 y 90%; y composiciones nutricionales para bebes.

Info

Publication number
CL2008003809A1
CL2008003809A1 CL2008003809A CL2008003809A CL2008003809A1 CL 2008003809 A1 CL2008003809 A1 CL 2008003809A1 CL 2008003809 A CL2008003809 A CL 2008003809A CL 2008003809 A CL2008003809 A CL 2008003809A CL 2008003809 A1 CL2008003809 A1 CL 2008003809A1
Authority
CL
Chile
Prior art keywords
protein
nutritional
lecithin
hydrolysis
degree
Prior art date
Application number
CL2008003809A
Other languages
English (en)
Inventor
Christine L Clinger
Jeffrey M Boff
Paul W Johns
Gary E Katz
Marti S Bergana
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40788959&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2008003809(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of CL2008003809A1 publication Critical patent/CL2008003809A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/10—Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composición que comprende carbohidrato, lípido con 0,25-2,5% de lecitina en peso de lípido total, 90-99,5% de proteína intacta y 0,5-10% de proteína hidrolizada seleccionada de caseína hidrolizada y proteína de suero hidrolizada en peso de proteína total, con un grado de hidrólisis entre 23-90%, la composición es polvo nutricional.
CL2008003809A 2007-12-20 2008-12-18 Composicion en polvo nutricional que comprende carboidratos, lipidos con 0,25 a 2,5% de lecitina, 90 a 99,5% de proteina intacta y 0,5 a 10% de proteina de suero con un grado de hidrolisis de entre 23 y 90%; y composiciones nutricionales para bebes. CL2008003809A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1531807P 2007-12-20 2007-12-20

Publications (1)

Publication Number Publication Date
CL2008003809A1 true CL2008003809A1 (es) 2009-10-16

Family

ID=40788959

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008003809A CL2008003809A1 (es) 2007-12-20 2008-12-18 Composicion en polvo nutricional que comprende carboidratos, lipidos con 0,25 a 2,5% de lecitina, 90 a 99,5% de proteina intacta y 0,5 a 10% de proteina de suero con un grado de hidrolisis de entre 23 y 90%; y composiciones nutricionales para bebes.

Country Status (25)

Country Link
US (1) US8377496B2 (es)
EP (1) EP2242382B1 (es)
JP (1) JP2011507518A (es)
CN (1) CN101951789B (es)
AR (1) AR070679A1 (es)
AU (1) AU2008343689A1 (es)
BR (1) BRPI0820584A2 (es)
CA (1) CA2708527C (es)
CL (1) CL2008003809A1 (es)
CO (1) CO6280447A2 (es)
CR (1) CR11508A (es)
DO (1) DOP2010000176A (es)
EC (1) ECSP10010262A (es)
GT (1) GT201000173A (es)
IL (1) IL206132A (es)
MX (1) MX2010006887A (es)
MY (1) MY168206A (es)
NZ (1) NZ585619A (es)
PA (1) PA8808701A1 (es)
PE (1) PE20091332A1 (es)
RU (1) RU2481008C2 (es)
SV (1) SV2010003599A (es)
TW (1) TWI418307B (es)
WO (1) WO2009085388A2 (es)
ZA (1) ZA201003912B (es)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1973406T3 (da) 2005-12-28 2014-06-23 Advanced Bionutrition Corp Fremføringsmiddel til probiotiske bakerier omfattende en tør blanding af polysaccharider, saccharider, polyoler i glasform
EP2117354B1 (en) 2006-12-18 2018-08-08 Advanced BioNutrition Corp. A dry food product containing live probiotic
US20090258833A1 (en) * 2008-04-10 2009-10-15 Edward Walker Fortified liquid protein compositions and methods of making same
EP2410996B1 (en) 2009-03-27 2017-08-02 Advanced Bionutrition Corp. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
RU2538691C2 (ru) 2009-04-29 2015-01-10 Амарин Фарма, Инк. Стабильные фармацевтические композиции и способы их применения
EP3563842A1 (en) 2009-04-29 2019-11-06 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
SG176253A1 (en) 2009-05-26 2011-12-29 Advanced Bionutrition Corp Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
LT3318255T (lt) 2009-06-15 2021-05-25 Amarin Pharmaceuticals Ireland Limited Kompozicijos ir būdai, skirti insulto gydymui pacientui kartu su statinų terapija
TW201112967A (en) * 2009-09-16 2011-04-16 Abbott Lab Dryblended nutritional powders
CA2775339C (en) 2009-09-23 2017-03-28 Amarin Corporation Plc Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
WO2011094469A2 (en) 2010-01-28 2011-08-04 Advanced Bionutrition Corporation Dry glassy composition comprising a bioactive material
US8840950B2 (en) * 2010-05-26 2014-09-23 Jacqueline M. Hibbert Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore
LT2603100T (lt) 2010-08-13 2018-07-25 Advanced Bionutrition Corp. Stabilizuojanti kompozicija, skirta biologinių medžiagų sausam saugojimui
US11712429B2 (en) 2010-11-29 2023-08-01 Amarin Pharmaceuticals Ireland Limited Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
NZ744990A (en) 2010-11-29 2019-10-25 Amarin Pharmaceuticals Ie Ltd Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
CN102599402B (zh) * 2011-01-25 2013-09-04 光明乳业股份有限公司 一种乳清蛋白组合物及其制备方法
ES2689225T3 (es) * 2011-02-07 2018-11-12 Abbott Laboratories Productos nutricionales que comprenden beta-hidroxi-beta-metilbutirato
CN102273520B (zh) * 2011-08-02 2013-08-07 中国科学院新疆理化技术研究所 乳清营养粉及其制备方法
US20130089638A1 (en) * 2011-10-11 2013-04-11 Mead Johnson Nutrition Company Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes
WO2013056038A2 (en) * 2011-10-14 2013-04-18 Abbott Laboratories Sterilized liquid protein supplement
US11291643B2 (en) 2011-11-07 2022-04-05 Amarin Pharmaceuticals Ireland Limited Methods of treating hypertriglyceridemia
EP2775837A4 (en) 2011-11-07 2015-10-28 Amarin Pharmaceuticals Ie Ltd METHODS OF TREATING HYPERTRIGLYCERIDEMIA
EP2800469B1 (en) 2012-01-06 2021-08-25 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering levels of high-sensitivity (hs-crp) in a subject
CN114601849A (zh) * 2012-03-23 2022-06-10 先进生物营养公司 生物材料的稳定化组合物
EP4342546A3 (en) 2012-06-29 2024-05-22 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
US20150265566A1 (en) 2012-11-06 2015-09-24 Amarin Pharmaceuticals Ireland Limited Compositions and Methods for Lowering Triglycerides without Raising LDL-C Levels in a Subject on Concomitant Statin Therapy
US20140187633A1 (en) 2012-12-31 2014-07-03 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
US9452151B2 (en) 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
US9624492B2 (en) 2013-02-13 2017-04-18 Amarin Pharmaceuticals Ireland Limited Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
US20140271841A1 (en) 2013-03-15 2014-09-18 Amarin Pharmaceuticals Ireland Limited Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin
US20140328970A1 (en) * 2013-05-03 2014-11-06 Mead Johnson Nutrition Company Nutritional Composition Comprising Whey and Hydrolyzed Casein and Uses Thereof
US10966968B2 (en) 2013-06-06 2021-04-06 Amarin Pharmaceuticals Ireland Limited Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
US20150065572A1 (en) 2013-09-04 2015-03-05 Amarin Pharmaceuticals Ireland Limited Methods of treating or preventing prostate cancer
US9585859B2 (en) 2013-10-10 2017-03-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
US10639334B2 (en) * 2014-01-07 2020-05-05 Mead Johnson Nutrition Company Pediatric nutritional composition with milk peptides for healthy growth and development
US10561631B2 (en) 2014-06-11 2020-02-18 Amarin Pharmaceuticals Ireland Limited Methods of reducing RLP-C
WO2015195662A1 (en) 2014-06-16 2015-12-23 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense ldl or membrane polyunsaturated fatty acids
EP3171713A1 (en) * 2014-07-21 2017-05-31 Abbott Laboratories Nutritional powder with specific antioxidants
WO2016014514A1 (en) * 2014-07-21 2016-01-28 Abbott Laboratories Nutritional powder with polyunsaturated fatty acid and improved organoleptic properties
CN107205448A (zh) * 2015-01-16 2017-09-26 威尔君克斯有限公司 含胶原蛋白和附加添加剂的饮料
US10953050B2 (en) 2015-07-29 2021-03-23 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses
US20180310605A1 (en) * 2015-10-15 2018-11-01 N.V. Nutricia Infant formula with milk fat for promoting healthy growth
EP3397078A1 (en) 2015-12-28 2018-11-07 Abbott Laboratories Nutritional compositions comprising hydrolyzed protein and a modified fat system and uses thereof
EP3410874B1 (en) * 2016-02-05 2021-05-05 Abbott Laboratories Whey protein based liquid nutritional composition
US10406130B2 (en) 2016-03-15 2019-09-10 Amarin Pharmaceuticals Ireland Limited Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
TW201900160A (zh) 2017-05-19 2019-01-01 愛爾蘭商艾瑪琳製藥愛爾蘭有限公司 用於降低腎功能下降之個體中的三酸甘油酯之組合物及方法
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
US11058661B2 (en) 2018-03-02 2021-07-13 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L
FI4056176T3 (fi) 2018-09-24 2024-05-30 Amarin Pharmaceuticals Ie Ltd Menetelmät kardiovaskulaaristen tapahtumien riskin pienentämiseksi tutkittavassa
WO2020172623A1 (en) * 2019-02-21 2020-08-27 Ingenuity Foods, Inc. Compositions comprising choline and omega-3 fatty acid to nutritionally enhance food products
AU2022263358A1 (en) 2021-04-21 2023-11-30 Amarin Pharmaceuticals Ireland Limited Methods of reducing the risk of heart failure
CN113632993A (zh) * 2021-08-24 2021-11-12 黑龙江八一农垦大学 黑豆-乳清双蛋白运动营养粉

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5024849A (en) 1990-05-01 1991-06-18 Nestec S.A. Liquid coffee whitener
US5021245A (en) * 1990-05-22 1991-06-04 Abbott Laboratories Infant formula containing a soy polysaccharide fiber source
CA2089920C (en) 1992-02-21 1999-06-15 John D. Johnston Synergistic compositions for extending animal feed shelf life
NL9300848A (nl) 1993-05-14 1994-12-01 Friesland Frico Domo Coop Werkwijze voor de bereiding van lang houdbare melkconcentraten en melkpoeders.
US5405637A (en) 1993-06-30 1995-04-11 Bristol-Myers Squibb Company Milk protein partial hydrolysate and infant formula containing same
US6136858A (en) * 1994-01-10 2000-10-24 Abbott Laboratories Infant formula and methods of improving infant stool patterns
WO1995018618A2 (en) * 1994-01-10 1995-07-13 Abbott Lab Enteral formula with ribo-nucleotides
US5635199A (en) 1995-10-27 1997-06-03 Nestec Ltd. Support of pediatric patients
IL131126A (en) * 1997-02-21 2003-04-10 Abbott Lab Compositions for reducing the incidence of necrotizing enterocolitis and the preparation thereof
EP1034704A1 (en) 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Nutritional composition intended for specific gastro-intestinal maturation in premature mammals
US6294206B1 (en) 1999-04-09 2001-09-25 Abbott Laboratories Powdered human milk fortifier
US6365218B1 (en) 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
US6207638B1 (en) 2000-02-23 2001-03-27 Pacifichealth Laboratories, Inc. Nutritional intervention composition for enhancing and extending satiety
ES2291406T3 (es) * 2001-11-26 2008-03-01 Nestec S.A. Composicion nutritiva auto-estable, que contiene proteina de suero lacteo, intacta, procedimiento de fabricacion y uso.
RU2262867C2 (ru) * 2002-02-14 2005-10-27 Катков Юрий Адольфович Бад к пище для улучшения репродукции человека (варианты)
US7070825B2 (en) 2002-09-10 2006-07-04 Abbott Laboratories Infant formula
TWI317636B (en) 2002-11-22 2009-12-01 Meiji Dairies Corp Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress
CA2558537A1 (en) 2004-03-12 2005-09-29 Nellson Northern Operating Inc. Novel protein layering masses, processes for the manufacture thereof, and related products
EP1839492B1 (en) 2006-03-27 2011-09-14 Nestec S.A. Whey protein micelles
CA2537647A1 (en) 2005-03-01 2006-09-01 Six Star Formulations Ltd. Supplemental dietary composition for supporting muscle growth, recovery and strength
US20060233915A1 (en) 2005-04-15 2006-10-19 Bristol-Myers Squibb Company Liquid nutritional product to supplement human milk
US7618669B2 (en) 2005-06-01 2009-11-17 Mead Johnson Nutrition Company Low-lactose partially hydrolyzed infant formula
DE102005031468A1 (de) 2005-07-04 2007-01-18 Basf Ag Wässrige Suspensionen schwer wasserlöslicher oder wasserunlöslicher Wirkstoffe und daraus hergestellte Trockenpulver
JP5118125B2 (ja) 2006-03-23 2013-01-16 ネステク ソシエテ アノニム 高カロリーの栄養補助食品
US7875303B2 (en) * 2006-03-31 2011-01-25 Kraft Foods Global Brands Llc Protein system and food products including same
US20070281054A1 (en) * 2006-05-31 2007-12-06 Abbott Laboratories Organic powder nutritional formula containing select carbohydrate combinations
WO2010047581A1 (en) 2008-10-24 2010-04-29 N.V. Nutricia Liquid high-fat protein composition

Also Published As

Publication number Publication date
GT201000173A (es) 2012-04-03
TWI418307B (zh) 2013-12-11
AR070679A1 (es) 2010-04-28
EP2242382B1 (en) 2016-11-16
RU2481008C2 (ru) 2013-05-10
CO6280447A2 (es) 2011-05-20
PA8808701A1 (es) 2009-07-23
CR11508A (es) 2011-08-12
CA2708527A1 (en) 2009-07-09
PE20091332A1 (es) 2009-09-30
CA2708527C (en) 2016-06-14
IL206132A0 (en) 2010-11-30
WO2009085388A2 (en) 2009-07-09
TW200932128A (en) 2009-08-01
MY168206A (en) 2018-10-15
AU2008343689A1 (en) 2009-07-09
DOP2010000176A (es) 2010-10-15
EP2242382A2 (en) 2010-10-27
RU2010129984A (ru) 2012-01-27
SV2010003599A (es) 2011-01-24
ECSP10010262A (es) 2010-07-30
WO2009085388A3 (en) 2010-09-02
ZA201003912B (en) 2011-06-29
CN101951789A (zh) 2011-01-19
US20090162518A1 (en) 2009-06-25
IL206132A (en) 2014-04-30
NZ585619A (en) 2012-06-29
MX2010006887A (es) 2010-10-15
BRPI0820584A2 (pt) 2015-07-14
US8377496B2 (en) 2013-02-19
CN101951789B (zh) 2014-02-05
JP2011507518A (ja) 2011-03-10

Similar Documents

Publication Publication Date Title
CL2008003809A1 (es) Composicion en polvo nutricional que comprende carboidratos, lipidos con 0,25 a 2,5% de lecitina, 90 a 99,5% de proteina intacta y 0,5 a 10% de proteina de suero con un grado de hidrolisis de entre 23 y 90%; y composiciones nutricionales para bebes.
CL2008003807A1 (es) Composicion en polvo nutrifcional que comprende carbhidratos, lipidos con 0,25 a 2,5% de lecitina, 0,5 a 10% de proteina hidrolizada y 90 a 99,5% de proteina intacta; y composiciones nutricionales para bebes.
CL2007002084A1 (es) Ingrediente lacteo enriquecido en fosfolipidos y esfingolipidos, en que el porcentaje de fosfolipidos es mayor a 36% con respeto al peso de la materia seca del ingrediente; procedimiento de obtencion; composicion alimentaria o aditivo que lo contiene; composicion farmaceutica o cosmetica; y su uso.
PE20151765A1 (es) Formulas a base de hidrolizado de aminoacido y proteina con un sistema estable de emulsion
BR112013020940A2 (pt) produto de proteína de soro de leite, método de produção e uso
CL2011003078A1 (es) Uso de una composicion nutricional para mantener, sostener y/o mejorar el desempeno cognitivo en un nino de 3 a 6 anos, que comprende al menos una fuente de proteina, una fuente de carbohidratos, una fuente de lipido, un microorganismo probiotico, y prebioticos, en donde la fuente de lipido comprende acido docosahexanoico (dha).
BR112012031183A2 (pt) líquidos nutricionais substancialmente claros compreendendo proteína de cálcio hmb e solúvel
CL2011000893A1 (es) Composicion nutricional para infantes en que comprende proteinas parcialmente hidrolizadas con un grado de hidrolisis de entre 5 y 40%, una fuente de lipido y una fuente de carbohidrato seleccionado entre almidon de cereal o de papa; y su uso para el manejo de la regurgitacion.
CO6630181A2 (es) Composiciones y métodos para uso de anticuerpos terapéuticos de lrp6( proteina relacionada con lipoproteínas de baja densidad 6)
BRPI0814971A8 (pt) Proteína
ECSP14000502A (es) Composiciones nutricionales de caseína-suero parcialmente hidrolizadas para reducir la aparición de alergias
CL2008003735A1 (es) Hidrolizado parcial de proteina de cereal con un grado de hidrolisis entre 9 y 18%; proceso de preparacion; harina de cereal; producto de cereal; y uso del hidrolizado parcial de proteinas de cereal.
ECSP13012807A (es) Composición que comprende proteínas de leche termolábiles y proceso para para preparar la misma
CL2007002915A1 (es) Composicion para alimentos, suplementos nutritivos, productos nutraceuticos u otros de consumo humano que comprende cloruro de sodio, cloruro de potasio, acidos y edulcorantes, donde las proporciones de dichos componentes confieren a la composicion p
AR099344A1 (es) Composición nutricional que comprende suero y caseína hidrolizada
PE20141022A1 (es) Composiciones y procedimientos para la administracion de nutrientes
PH12020500452A1 (en) Infant formula having decreased protein content
BRPI1010340A8 (pt) Manipulador de documento
TH115365A (th) ผงที่มีสารอาหาร ที่คงตัว
TH164103B (th) สูตรที่มีกรดอะมิโนและไฮโดรไลเซตโปรตีนเป็นพื้นฐานที่มีระบบอิมัลชัน ที่มีความเสถียร
TH96496S (th) ตู้ใส่เสื้อผ้า
TH115364A (th) ผงที่มีสารอาหาร ที่คงตัว
TH46267S1 (th) รถเกี่ยวข้าว
TH102540S (th) กล่องบรรจุ
TH40171S1 (th) เก้าอี้